BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2302103)

  • 21. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.
    Meecham WJ; Char DH; Kroll S; Castro JR; Blakely EA
    Arch Ophthalmol; 1994 Feb; 112(2):197-203. PubMed ID: 8311772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Eur J Ophthalmol; 2013; 23(3):399-409. PubMed ID: 23483500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT
    Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciliary body melanoma treated with helium particle irradiation.
    Decker M; Castro JR; Linstadt DE; Char D; Petti PL; Quivey JM; Ahn D
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):243-7. PubMed ID: 2118491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
    PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
    Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
    Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
    Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
    Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of proton radiotherapy for uveal melanomas.
    Egger E; Zografos L; Munkel G; Böhringer T; Bercher L; Chamot L
    Front Radiat Ther Oncol; 1997; 30():111-22. PubMed ID: 9205891
    [No Abstract]   [Full Text] [Related]  

  • 31. Irradiated uveal melanomas: cytopathologic correlation with prognosis.
    Char DH; Kroll SM; Miller T; Castro J; Quivey J
    Am J Ophthalmol; 1996 Oct; 122(4):509-13. PubMed ID: 8862047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of proton beam irradiated uveal melanomas.
    Gragoudas ES; Seddon JM; Egan K; Glynn R; Munzenrider J; Austin-Seymour M; Goitein M; Verhey L; Urie M; Koehler A
    Ophthalmology; 1987 Apr; 94(4):349-53. PubMed ID: 3035451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications after proton beam therapy for uveal malignant melanoma. A clinical and histopathologic study of five cases.
    Kincaid MC; Folberg R; Torczynski E; Zakov ZN; Shore JW; Liu SJ; Planchard TA; Weingeist TA
    Ophthalmology; 1988 Jul; 95(7):982-91. PubMed ID: 2845323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uveal melanoma: development of metastases after helium ion irradiation.
    Nowakowski VA; Ivery G; Castro JR; Char DH; Linstadt DE; Ahn D; Phillips TL; Quivey JM; Decker M; Petti PL
    Radiology; 1991 Jan; 178(1):277-80. PubMed ID: 1898536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helium ion charged-particle therapy for choroidal melanoma. Histopathologic findings in a successfully treated case.
    Grizzard WS; Torczynski E; Char DH
    Arch Ophthalmol; 1984 Apr; 102(4):576-8. PubMed ID: 6704015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study.
    Linstadt D; Char DH; Castro JR; Phillips TL; Quivey JM; Reimers M; Hannigan J; Collier JM
    Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):347-52. PubMed ID: 3403315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cataract extraction after proton beam irradiation for malignant melanoma of the eye.
    Gragoudas ES; Egan KM; Arrigg PG; Seddon JM; Glynn RJ; Munzenrider JE
    Arch Ophthalmol; 1992 Apr; 110(4):475-9. PubMed ID: 1562251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.